A perfused beating rabbit atrial model was used. The ANP and ET-1 levels in the atrial perfusates were measured by radioimmunoassays.
Ouabain (1.0, 3.0 and 6.0 渭mol/L) significantly increased atrial ANP secretion in a dose-dependent manner, while the endothelin (ET)-1 levels were increased by the higher doses (3.0 and 6.0 渭mol/L) of ouabain. Ouabain-increased atrial ET-1 release was blocked by PD98059 (30.0 渭mol/L), an inhibitor of mitogen-activated protein kinase (MAPK). Nifedipine (1.0 渭mol/L), an inhibitor of L-type Ca2+ channels, completely abolished ouabain-increased ANP secretion without changing the ouabain-induced atrial dynamics. KB-R7943 (3.0 渭mol/L), an inhibitor of Na+-Ca2+ exchangers, completely blocked the effects of ouabain-increased atrial dynamics, but did not modulate ouabain-increased ANP secretion. ET-1 significantly stimulated atrial ANP release in a dose-dependent manner. The effects of ET-1 and ouabain on ANP secretion were completely blocked by BQ788 (0.3 渭mol/L), an inhibitor of ET-1 type B (ETB) receptors, but not by BQ123 (0.3 渭M), an inhibitor of ET-1 type A receptors. Ouabain-increased atrial ANP secretion was blocked by PD98059 and indomethacin (30.0 渭mol/L), an inhibitor of cyclooxygenase.
Ouabain significantly stimulated atrial ANP secretion via an ET-1-ETB receptor-mediated pathway involving MAPK signaling pathway activation and prostaglandin formation.